Mifepristone

Trump Administration Pushes to Dismiss Federal Challenge Against Mifepristone Access Amid Ongoing Legal Battle

by

Washington — The Justice Department on Monday called on a federal court to dismiss a lawsuit aiming to challenge the expansion of access to the abortion pill mifepristone. This lawsuit, initiated by Missouri, Idaho, and Kansas, takes issue with the Food and Drug Administration’s (FDA) regulatory changes concerning the medication, which is commonly used to terminate early pregnancies. In a filing submitted to the U.S. District Court in Amarillo, Texas, Justice Department lawyers argued that the states lack the right to pursue this case in the specified jurisdiction. The administration is supporting a request made … Read more

Texas Federal Judge Revives Key Lawsuit Challenging Mifepristone Approval, Influencing Future Abortion Access Across States

by

Austin, Texas — In a significant legal revival, a federal judge in Texas has reinstated a lawsuit targeting the FDA’s approval of the abortion medication mifepristone, stirring fresh controversy just days ahead of the 52nd anniversary of the landmark Roe v. Wade decision. This unfolding legal battle underscores the persistent national divide over abortion rights following the Supreme Court’s 2022 decision to overturn Roe v. Wade, which had previously enshrined federal abortion protections. The revived lawsuit, which had been dismissed last year, challenges the loosened regulations surrounding the distribution of mifepristone, a drug used both … Read more